AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Barr Receives Tentative Approval For Generic Mircette Oral Contraceptive.(Brief Article)

Women's Health Weekly

| January 03, 2002 | COPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2001 DEC 27 - (NewsRx.com & NewsRx.net) -- Barr Laboratories, Inc., has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Mircette, Organon, Inc.'s, oral contraceptive. The application, which is the subject of a patent challenge that is expected to come to trial in calendar 2002, was acquired by Barr as part of its recent merger with Duramed Pharmaceuticals, Inc.

Mircette is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. The product has annual sales of $102 million for the most recent 12 months. Mircette is a 28-tablet regimen that represents a combination of desogestrel/ethinyl estradiol and ethinyl estradiol.

"Barr is committed to building a full line of generic oral contraceptive products. Challenging vulnerable patents protecting brand versions of select products is a component of that strategy," said Bruce L. Downey, Barr's chairman and CEO. "In addition to Mircette, we are also ...

Related articles from newspapers, magazines, journals, and more
Barr Receives Tentative Approval For Generic Mircette Oral Contraceptive.
Newspaper article from: Drug Week December 28, 2001 700+ words
...Organon, Inc.'s, oral contraceptive. The application...line of generic oral contraceptive products. Challenging vulnerable patents protecting brand versions of...challenging the patents protecting Pfizer's Estrostep...
Barr Files IND for SEASONALE(TM) Oral Contraceptive.
Press release article from: PR Newswire May 23, 2000 700+ words
...forms, two additional oral contraceptive products, one hormonal...s challenge of the patents protecting Eli Lilly's PROZAC...efforts challenging the patents protecting the Ortho/Novum 7/7/7 oral contraceptive are expected to result...
Barr Initiates Challenge of Patent Protecting Ortho Tri-Cyclen Oral...
Press release article from: PR Newswire June 13, 2000 700+ words
...challenge of the patents protecting Ortho-McNeil...Cyclen oral contraceptive. Ortho Tri...brand name oral contraceptive to American...challenging the patents protecting the Ortho...7/7/7 oral contraceptive, which has...
Barr Initiates Challenge of Ortho-Novum 7/7/7 Patents; $160 Million Oral...
Press release article from: PR Newswire February 8, 1999 700+ words
...challenge of the patents protecting Ortho Pharmaceutical...7/7/7 oral contraceptive. Ortho...development of oral contraceptive products...launched an oral contraceptive development...that the patents protecting it from competition...
Nortel 7/7/7 receives final FDA approval.(oral contraceptive)(Brief Article)
Magazine article from: Women's Health Weekly October 24, 2002 700+ words
...Ortho-McNeil Pharmaceutical's Ortho-Novum 7/7/7 oral contraceptive. The company plans to launch its generic version in January...license effective January 1, 2003, 9 months before the patents protecting the product expire in September 2003. As part of the...
An Essential Report on China's Oral Contraceptive Drugs Industry.
Press release article from: M2 Presswire July 28, 2009 700+ words
...Essential Report on China's Oral Contraceptive Drugs Industry(C)1994-2009...of the "Report on China's Oral Contraceptive Drugs Industry" report to their offering. The oral contraceptive drug has two major components...
BIOSANTE PHARMA ANNOUNCES ORAL CONTRACEPTIVE PHASE II STUDY.(Clinical report)
News wire article from: AsiaPulse News June 20, 2007 700+ words
...BioSante Pharmaceuticals Announces Oral Contraceptive Phase II Study Initiation LINCOLNSHIRE...human clinical trial of a new oral contraceptive. BioSante will co-fund the development of the oral contraceptive up to $1.0 million. Pantarhei...
Obesity and Oral Contraceptive Efficacy.
Newspaper article from: Emergency Medicine Reports August 1, 2009 700+ words
Obesity and Oral Contraceptive Efficacy Abstract & Commentary...small effect of obesity on oral contraceptive efficacy but this finding was...question -- does obesity affect oral contraceptive efficacy? Nevertheless, should...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA